Christina J. Allain

3.6k total citations · 2 hit papers
10 papers, 1.4k citations indexed

About

Christina J. Allain is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Christina J. Allain has authored 10 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Christina J. Allain's work include Cancer-related gene regulation (5 papers), Phosphodiesterase function and regulation (4 papers) and Epigenetics and DNA Methylation (4 papers). Christina J. Allain is often cited by papers focused on Cancer-related gene regulation (5 papers), Phosphodiesterase function and regulation (4 papers) and Epigenetics and DNA Methylation (4 papers). Christina J. Allain collaborates with scholars based in United States. Christina J. Allain's co-authors include Victoria M. Richon, Roy M. Pollock, Robert A. Copeland, Richard Chesworth, Mikel P. Moyer, Margaret Porter Scott, Christine R. Klaus, Alejandra Raimondi, Kevin W. Kuntz and Sarah K. Knutson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Christina J. Allain

10 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2

2013 581 citations Sarah K. Knutson, Natalie M. Warholic et al. Proceedings of the National Academy of Sciences profile →
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia

2013 546 citations Scott R. Daigle, Edward J. Olhava et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christina J. Allain United States	9	1.3k	200	137	112	92	10	1.4k
Nanni Huser United States	8	737 0.6×	68 0.3×	238 1.7×	73 0.7×	79 0.9×	15	999
Anqi Ma United States	20	1.2k 0.9×	200 1.0×	159 1.2×	47 0.4×	39 0.4×	31	1.3k
Gregg Timony United States	11	545 0.4×	78 0.4×	73 0.5×	119 1.1×	107 1.2×	24	882
Tadakazu Akiyama Japan	15	561 0.4×	116 0.6×	303 2.2×	44 0.4×	117 1.3×	17	832
Jeffrey D. Bray United States	12	441 0.3×	95 0.5×	139 1.0×	68 0.6×	47 0.5×	20	885
Kimberly N. Smitheman United States	11	856 0.7×	136 0.7×	345 2.5×	112 1.0×	131 1.4×	11	1.0k
Ana M. Cosialls Spain	18	601 0.5×	70 0.3×	255 1.9×	92 0.8×	27 0.3×	29	842
Paul Tapang United States	14	444 0.4×	149 0.7×	236 1.7×	58 0.5×	143 1.6×	29	773
Neil MacLean Canada	17	588 0.5×	167 0.8×	253 1.8×	30 0.3×	34 0.4×	38	816
Mercè de Frías Spain	13	511 0.4×	75 0.4×	237 1.7×	94 0.8×	25 0.3×	17	734

Countries citing papers authored by Christina J. Allain

Since Specialization

Citations

This map shows the geographic impact of Christina J. Allain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina J. Allain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina J. Allain more than expected).

Fields of papers citing papers by Christina J. Allain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina J. Allain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina J. Allain. The network helps show where Christina J. Allain may publish in the future.

Co-authorship network of co-authors of Christina J. Allain

This figure shows the co-authorship network connecting the top 25 collaborators of Christina J. Allain. A scholar is included among the top collaborators of Christina J. Allain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina J. Allain. Christina J. Allain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Wyman, Arlene R., Manal Alaamery, Christina J. Allain, et al.. (2017). Identification and characterization of a potent and biologically-active PDE4/7 inhibitor via fission yeast-based assays. Cellular Signalling. 40. 73–80. 12 indexed citations

Kuntz, Kevin W., John E. Campbell, Heike Keilhack, et al.. (2016). The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat. Journal of Medicinal Chemistry. 59(4). 1556–1564. 127 indexed citations

Basavapathruni, Aravind, Edward J. Olhava, Scott R. Daigle, et al.. (2014). Nonclinical pharmacokinetics and metabolism of EPZ‐5676, a novel DOT1L histone methyltransferase inhibitor. Biopharmaceutics & Drug Disposition. 35(4). 237–252. 64 indexed citations

Daigle, Scott R., Edward J. Olhava, Aravind Basavapathruni, et al.. (2013). Potent inhibition of DOT1L as treatment of MLL-fusion leukemia. Blood. 122(6). 1017–1025. 546 indexed citations breakdown →

Knutson, Sarah K., Natalie M. Warholic, Tim J. Wigle, et al.. (2013). Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2. Proceedings of the National Academy of Sciences. 110(19). 7922–7927. 581 indexed citations breakdown →

Pollock, Roy M., Scott R. Daigle, Aravind Basavapathruni, et al.. (2012). Preclinical Characterization of a Potent, Selective Inhibitor of the Protein Methyltransferase DOT1L for Use in the Treatment of MLL-Rearranged Leukemia.. Blood. 120(21). 2379–2379. 3 indexed citations

Alaamery, Manal, Arlene R. Wyman, F. Douglas Ivey, et al.. (2010). New Classes of PDE7 Inhibitors Identified by a Fission Yeast-Based HTS. SLAS DISCOVERY. 15(4). 359–367. 22 indexed citations

Demirbas, Didem, Arlene R. Wyman, F. Douglas Ivey, et al.. (2010). Use of a Schizosaccharomyces pombe PKA-repressible reporter to study cGMP metabolising phosphodiesterases. Cellular Signalling. 23(3). 594–601. 17 indexed citations

Pollock, Roy M., Scott R. Daigle, Edward J. Olhava, et al.. (2010). Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor. Blood. 116(21). 780–780. 8 indexed citations

10.

Ivey, F. Douglas, Lili Wang, Didem Demirbas, Christina J. Allain, & Charles S. Hoffman. (2008). Development of a Fission Yeast-Based High-Throughput Screen to Identify Chemical Regulators of cAMP Phosphodiesterases. SLAS DISCOVERY. 13(1). 62–71. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact